Literature DB >> 19868584

EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : VI. IMMUNITY REACTIONS.

P K Olitsky1, F L Gates.   

Abstract

The experiments described furnish additional evidence of the pathogenic character and the virtual identity of the various strains of the active agent derived from the nasopharyngeal secretions of influenzal patients with which the transmission experiments in rabbits have been carried out. The active material has been shown to be of antigenic nature, so that rabbits are protected from the effects of a second inoculation. The experiments indicate also the antigenic identity of the various strains of the active agent with each other and with Bacterium pneumosintes. Finally, the experiments show that the protection may persist for 14 months which is the longest period yet tested.

Entities:  

Year:  1922        PMID: 19868584      PMCID: PMC2180242          DOI: 10.1084/jem.35.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : I. TRANSMISSION EXPERIMENTS WITH NASOPHARYNGEAL WASHINGS.

Authors:  P K Olitsky; F L Gates
Journal:  J Exp Med       Date:  1921-01-31       Impact factor: 14.307

2.  EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : IV. ANAEROBIC CULTIVATION.

Authors:  P K Olitsky; F L Gates
Journal:  J Exp Med       Date:  1921-05-31       Impact factor: 14.307

  2 in total
  2 in total

1.  AN ATTEMPT TO ISOLATE A FILTER-PASSING VIRUS IN EPIDEMIC INFLUENZA.

Authors:  H K Detweiler; W R Hodge
Journal:  J Exp Med       Date:  1924-01-01       Impact factor: 14.307

2.  EXPERIMENTAL STUDIES OF THE NASOPHARYNGEAL SECRETIONS FROM INFLUENZA PATIENTS : XI. ANTIBODIES IN THE BLOOD AFTER RECOVERY FROM EPIDEMIC INFLUENZA.

Authors:  P K Olitsky; F L Gates
Journal:  J Exp Med       Date:  1923-02-28       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.